FDA Inspection 1205607 — Biolife Plasma Services L.P.

Biolife Plasma Services L.P. — FEI 3011109020

The FDA completed an inspection of Biolife Plasma Services L.P. on May 18, 2023 in Loveland, CO. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 18, 2023
Fiscal Year
2023
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Loveland, CO (United States)

Citations

IDCFRDescription
1807921 CFR 630.10(d)(4)Physical Assessment of Donor